| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Acura Pharmaceuticals Inc (OTCQB: ACUR)
ACUR Technical Analysis
1
| As on 30th Dec 2025 ACUR STOCK Price closed @ 0.00 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ACURSTOCK Price
| Open | 0.00 | Change | Price | % |
| High | 0.00 | 1 Day | N/A | N/A |
| Low | 0.00 | 1 Week | 0.00 | 0.00 |
| Close | 0.00 | 1 Month | 0.00 | 0.00 |
| Volume | 5742 | 1 Year | 0.00 | 0.00 |
| 52 Week High 0.00 | 52 Week Low 0.00 | ||||
OTCQB USA Most Active Stocks
| SPYR | 0.00 | % |
| EMED | 0.00 | % |
| SOWG | 0.46 | % |
| BLEG | 0.00 | % |
| WDLF | 0.00 | % |
| BMIX | 0.01 | % |
| FNMA | 6.10 | % |
| BEGI | 0.00 | % |
| GRSLF | 0.23 | % |
| VPLM | 0.01 | % |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| ACUR Daily Charts |
ACUR Intraday Charts |
Whats New @ Bazaartrend |
ACUR Free Analysis |
|
|
ACUR Important Levels Intraday
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
ACUR Forecast March 2026
| 4th UP Forecast | 0 |
| 3rd UP Forecast | 0 |
| 2nd UP Forecast | 0 |
| 1st UP Forecast | 0 |
| 1st DOWN Forecast | 0 |
| 2nd DOWN Forecast | 0 |
| 3rd DOWN Forecast | 0 |
| 4th DOWN Forecast | 0 |
ACUR Weekly Forecast
| 4th UP Forecast | 0.00 |
| 3rd UP Forecast | 0.00 |
| 2nd UP Forecast | 0.00 |
| 1st UP Forecast | 0.00 |
| 1st DOWN Forecast | 0.00 |
| 2nd DOWN Forecast | 0.00 |
| 3rd DOWN Forecast | 0.00 |
| 4th DOWN Forecast | 0.00 |
ACUR Forecast2026
| 4th UP Forecast | 0 |
| 3rd UP Forecast | 0 |
| 2nd UP Forecast | 0 |
| 1st UP Forecast | 0 |
| 1st DOWN Forecast | 0 |
| 2nd DOWN Forecast | 0 |
| 3rd DOWN Forecast | 0 |
| 4th DOWN Forecast | 0 |
Acura Pharmaceuticals Inc ( OTCQB USA Symbol : ACUR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ACUR Business Profile
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was incorporated in 1935 and is based in Palatine, Illinois. Address: 616 N. North Court, Palatine, IL, United States, 60067
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service